Abera Bioscience AB (8WK) Stock Price & Analysis

8WK Stock Chart & Stats

€0.63€0.03(4.29%)

At close: Oct 30 5:30 PM GMT+1

Day’s Range: EUR 0.59 - EUR 0.63
52-Week Range: EUR 0.44 - EUR 0.97
Previous Close: EUR 0.61
Volume: 0
Average Volume (3M): 0
Market Cap: EUR 14.97M
Enterprise Value: EUR 15.81M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): EUR 0
Price to Earnings (P/E): ―
Beta: 1.23
Next Earnings: Nov 17, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

8WK FAQ

What was Abera Bioscience AB’s price range in the past 12 months?

Abera Bioscience AB lowest stock price was €0.44 and its highest was €0.97 in the past 12 months.

What is Abera Bioscience AB’s market cap?

Abera Bioscience AB’s market cap is €14.97M.

When is Abera Bioscience AB’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Abera Bioscience AB’s earnings last quarter?

Abera Bioscience AB released its earnings results on Aug 20, 2026. The company reported -€0.025 earnings per share for the quarter.

Is Abera Bioscience AB overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Abera Bioscience AB pay dividends?

Abera Bioscience AB does not currently pay dividends.

What is Abera Bioscience AB’s EPS estimate?

Abera Bioscience AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Abera Bioscience AB have?

Abera Bioscience AB has 21,457,134 shares outstanding.

What happened to Abera Bioscience AB’s price movement after its last earnings report?

Abera Bioscience AB reported an EPS of -€0.025 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Abera Bioscience AB?

Currently, no hedge funds are holding shares in DE:8WK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description